- AYTU Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Aytu BioPharma (AYTU) CORRESPCorrespondence with SEC
Filed: 3 Oct 18, 12:00am
Aytu BioScience, Inc.
373 Inverness Parkway, Suite 206
Englewood, CO 80112
October 3, 2018
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Attention: Irene Paik
Re: | Aytu BioScience, Inc. – Registration Statement on Form S-1 (File No. 333-227243) |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1 (File No. 333-227243), as amended (the “Registration Statement”) of Aytu BioScience, Inc. We respectfully request that the Registration Statement become effective as of 5:00 p.m., Eastern Time, on October 4, 2018, or as soon thereafter as is practicable. Once the Registration Statement has been declared effective, please confirm orally that event with our counsel, Dorsey & Whitney LLP, by calling Anthony Epps at (303) 352-1109.
Very truly yours, | ||
Aytu BioScience, Inc. | ||
By: | /s/ Joshua R. Disbrow | |
Name: | Joshua R. Disbrow | |
Title: | Chairman and Chief Executive Officer |